Literature DB >> 29632033

New generic pricing scheme maintains high prices and risks of shortages.

Steven G Morgan1, Nav Persaud2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29632033      PMCID： PMC5893313          DOI： 10.1503/cmaj.180197

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  1 in total

1.  International best practices for negotiating 'reimbursement contracts' with price rebates from pharmaceutical companies.

Authors:  Steven Morgan; Jamie Daw; Paige Thomson
Journal:  Health Aff (Millwood)       Date:  2013-04       Impact factor: 6.301
  1 in total
  4 in total

1.  In defense of Canada's drug plan managers.

Authors:  Aidan Hollis
Journal:  CMAJ       Date:  2018-06-25       Impact factor: 8.262

2.  Do practice guidelines cause drug shortages? The historical example of β-blockers.

Authors:  Jacalyn Duffin
Journal:  CMAJ       Date:  2019-09-16       Impact factor: 8.262

Review 3.  Drug Shortage: Causes, Impact, and Mitigation Strategies.

Authors:  Sundus Shukar; Fatima Zahoor; Khezar Hayat; Amna Saeed; Ali Hassan Gillani; Sumaira Omer; Shuchen Hu; Zaheer-Ud-Din Babar; Yu Fang; Caijun Yang
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

4.  Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study.

Authors:  Sergei Muratov; Justin Lee; Anne Holbrook; Jason Robert Guertin; Lawrence Mbuagbaw; John Michael Paterson; Tara Gomes; Priscila Pequeno; Jean-Eric Tarride
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.